DISCLOSURE. Mitral ViV: why? Mitral Valve- in- Valve: Procedural Image Guidance with TEE, a Must Have or Nice to Have? UW Medicine NONE.

Size: px
Start display at page:

Download "DISCLOSURE. Mitral ViV: why? Mitral Valve- in- Valve: Procedural Image Guidance with TEE, a Must Have or Nice to Have? UW Medicine NONE."

Transcription

1 Mitral Valve- in- Valve: Procedural Image Guidance with TEE, a Must Have or Nice to Have? G. Burkhard Mackensen, MD, PhD, FASE Professor & Chief, Division of Cardiothoracic Anesthesia, Department of Anesthesiology & Pain Medicine Research & Education Endowed Professor in Anesthesiology 1 DISCLOSURE NONE Mitral ViV: why? Growing numbers of mitral biological prostheses are being implanted in clinical practice Incidence of failing mitral biological prostheses is increasing over time Transcatheter ViV implantation may be a lower risk alternative treatment for high- risk patients with MV degeneration

2 Need for a less invasive and safer options for MV replacement following surgical implantantion of bioprosthetic valves Goals of percutaneous replacement Complete elimination of MS and/or MR Minimize risk of LVOT obstruction Minimize risk of paravalvular leak Address wide range of patient sizes Durability Improve outcomes compared to surgical MVR Series of 23 patients (MR, MS and mixed) Minimal morbidity and low operative mortality Clinical and hemodynamic outcomes were favorable at short- and midterm follow- up The transapical approach appeared particularly well suited to mitral TVIV MV VIV: TEE is a Must Have Determine the mode of bioprosthetic failure and true internal dimension to confirm ViV size Assess risk of LVOT obstruction Evaluate access site (transseptal versus apical) Confirm ViV position and angulation prior to deployment Assess need for post- implant dilation to ensure flaired or conical shape Functional assessment & rule out complications (pericardial effusion, LVOT obstruction, leak)

3 ViV Mitral app By UBQO Limited Dr. Vinayak Bapat ViV Mitral app By UBQO Limited Dr. Vinayak Bapat ViV Mitral app By UBQO Limited Dr. Vinayak Bapat

4 LVOT obstruction and aorto- mitral angle AoV Aorto- Mitral Angle Blanke P. et al.: JACC Cardiovasc Imaging in PRESS LVOT obstruction and Neo- LVOT Blanke P. et al.: JACC Cardiovasc Imaging in PRESS Mitral paravalvular leak closure with concomitant transcatheter valve-in-valve implantation An 81 year old male patient presented with symptoms of increasing fatigue and dyspnea on exertion. Congestive heart failure treatment. S/P CABG, bioprosthetic aortic (25mm Hancock II Ultra ) and bioprosthetic mitral (27mm Carpentier Edwards ) valve replacements in 2007 S/P AV nodal ablation therapy for chronic Afib with ICD implantation for recurrent VT TTE & TEE: mod- sec prosthetic MV stenosis and at least moderate paravalvular mitral regurgitation.

5 Procedural TEE Procedural TEE Procedural TEE

6 Procedural TEE Procedural TEE Procedural TEE

7 Procedural TEE Procedural TEE - deployment of Melody valve Procedural TEE - Melody valve deployed

8 Procedural TEE - Melody valve deployed Procedural TEE - Melody valve deployed CASE: Mitral annular calcification, MS & MR This is a 71 year old male with history of CABG, mechanical AVR Atrial fibrillation, COPD Admitted with CHF and volume overload, progressive SOB AKI on CKD TTE with moderate mitral stenosis with a mean gradient of 7mmHg, moderate mitral regurgitation (MR) Severe pulmonary arterial hypertension (PASP 70-75mmHG) Severe mitral annular calcification (MAC)

9 Predicting LVOT Obstruction Blanke P et al. J A C C : C A R D I O V A S C U L A R IMA G I N G 2016

10

11 Procedural image guidance Procedural image guidance Procedural image guidance

12 Procedural image guidance Procedural image guidance Summary Successful trans- apical MV replacement with a (aortic) Sapien XT valve, for the novel indication of mixed mitral stenosis and regurgitation Few case reports in North America Further multicenter research/registry work is necessary to evaluate effectiveness and comparative risk of this novel intervention.

13 CONCLUSION: TEE is essential to assess true internal dimension to confirm ViV size risk of LVOT obstruction access site (transseptal versus apical) and guide approach ViV position and angulation prior to deployment need for post- implant dilation to ensure flaired or conical shape function & possible complications University of Washington Medical Center Regional Heart Center Thank you Thank you and see see you you in Seattle in Seattle at Sessions 2016 at ASE Scientific Sessions 2016

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique

Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Bioprosthetic Mitral Valve Dysfunction: Innovation and Evolution of a New Therapeutic Technique Charanjit S. Rihal MD MBA Professor and Chair Division of Cardiovascular Diseases Mayo Clinic DISCLOSURES

More information

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min

How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, :00 11:25 PM 25 min 2016 ASE State of the Art Echocardiography Course Tucson, AZ How Do I Evaluate a Patient Being Considered for TAVR? Sunday, February 14, 2016 11:00 11:25 PM 25 min 1 M U H A M E D S A R I Ć, M D, P H D

More information

PARAVALVULAR LEAK POST TAVR. Elements of Follow-up Post TAVR

PARAVALVULAR LEAK POST TAVR. Elements of Follow-up Post TAVR PARAVALVULAR LEAK POST TAVR David S Rubenson MD FACC FASE Founding Director, Cardiac Non-Invasive Laboratory Scripps Clinic Medical Group number 1 Elements of Follow-up Post TAVR JACC CV Imag 2016;9:193

More information

Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses

Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses Review Article Transcatheter valve-in-valve implantation for degenerated surgical bioprostheses Dale J. Murdoch, John G. Webb Centre for Heart Valve Innovation, St. Paul s Hospital, Vancouver, Canada Contributions:

More information

Successful Percutaneous Closure of Mitral Bioprosthetic Paravalvular Leak Using Figulla ASD Occluder

Successful Percutaneous Closure of Mitral Bioprosthetic Paravalvular Leak Using Figulla ASD Occluder Hans R. Figulla, M.D., PhD ; Ali Hamadanchi, M.D. Medicine, Pneumology Universitity Hospital, Jena, Germany Successful Percutaneous Closure of Mitral Bioprosthetic Paravalvular Leak Using Figulla ASD Occluder

More information

Percutaneous Therapy for Calcific Mitral Valve Disease

Percutaneous Therapy for Calcific Mitral Valve Disease 31 st Annual State of the Art Echocardiography San Diego, CA February 18, 2018 5:00 5:15 PM 15 min Percutaneous Therapy for Calcific Mitral Valve Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive

More information

MITRAL (Mitral Implantation of TRAnscatheter valves)

MITRAL (Mitral Implantation of TRAnscatheter valves) MITRAL (Mitral Implantation of TRAnscatheter valves) 30-Day Outcomes of Transcatheter MV Replacement in Patients With Severe Mitral Valve Disease Secondary to Mitral Annular Calcification or Failed Annuloplasty

More information

TAVR: Echo Measurements Pre, Post And Intra Procedure

TAVR: Echo Measurements Pre, Post And Intra Procedure 2017 ASE Florida, Orlando, FL October 10, 2017 8:00 8:25 AM 25 min TAVR: Echo Measurements Pre, Post And Intra Procedure Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate

More information

Culprit vs Multivalve Transcatheter Intervention

Culprit vs Multivalve Transcatheter Intervention Culprit vs Multivalve Transcatheter Intervention Howard C. Herrmann, MD, FACC, MSCAI John Bryfogle Professor of Cardiovascular Medicine and Surgery Health System Director for Interventional Cardiology

More information

TMVR Transcatheter Valve-in-Valve: Technical Considerations

TMVR Transcatheter Valve-in-Valve: Technical Considerations TMVR Transcatheter Valve-in-Valve: Technical Considerations JOHN C. MESSENGER, MD, FACC, FSCAI PROFESSOR OF MEDICINE DIRECTOR, CARDIAC CATHETERIZATION LABS UNIVERSITY OF COLORADO SCHOOL OF MEDICINE Disclosures:

More information

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)

Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI) Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI) Larry S. Dean, MD, MSCAI Past President SCAI Professor of Medicine and Surgery University of Washington School of Medicine

More information

Critical role of multi-modality planning in Transcatheter Mitral Valve Replacement

Critical role of multi-modality planning in Transcatheter Mitral Valve Replacement Critical role of multi-modality planning in Transcatheter Mitral Valve Replacement Dee Dee Wang, MD, FACC, FASE, FSCCT Director Structural Heart Imaging Medical Director 3D Printing Henry Ford Innovations

More information

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients?

After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? After PARTNER 2A/S3i and SURTAVI: What is the Role of Surgery in Intermediate-Risk AS Patients? Vinod H. Thourani, MD Professor of Surgery and Medicine Emory University Disclosure Statement of Financial

More information

Federico M Asch MD, FASE MedStar Heart and Vascular Institute Georgetown University Washington, DC

Federico M Asch MD, FASE MedStar Heart and Vascular Institute Georgetown University Washington, DC TAVR: When Things go Wrong Federico M Asch MD, FASE MedStar Heart and Vascular Institute Georgetown University Washington, DC Disclosures Academic Echo Core Lab Abbott / St Jude Medical Edwards Medtronic

More information

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation

The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation The FORMA Early Feasibility Study: 30-Day Outcomes of Transcatheter Tricuspid Valve Therapy in Patients with Severe Secondary Tricuspid Regurgitation Susheel Kodali, MD Director, Structural Heart & Valve

More information

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route Transcatheter Aortic Valve Implantation Asian perspective Speakers s name: Paul Chiam Paul TL Chiam MBBS, MRCP, FACC I have the following potential conflicts of interest to report: NONE Consultant National

More information

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology

TAVR for Valve-In-Valve. Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology TAVR for Valve-In-Valve Brian O Neill Assistant Professor of Medicine Department of Medicine, Section of Cardiology Temple Hearth and Vascular Institute Disclosures: Consultant: Cardiac Assist TAVR for

More information

Percutaneous Valve in Native With and Without Mitral Valve Calcification: When To Go Hybrid

Percutaneous Valve in Native With and Without Mitral Valve Calcification: When To Go Hybrid Percutaneous Valve in Native With and Without Mitral Valve Calcification: When To Go Hybrid Deborah Tabachnick, MD Cardiac Surgeon The Heart Hospital Baylor Plano Baylor Scott & White Health Disclosures

More information

Blank DISCLOSURES 1/17/2017 COMPLEX VALVE CASES CHALLENGES IN EVALUATING AND MANAGING MULTIVALVULAR HEART DISEASE ECHO HAWAII 1/23/17 NONE

Blank DISCLOSURES 1/17/2017 COMPLEX VALVE CASES CHALLENGES IN EVALUATING AND MANAGING MULTIVALVULAR HEART DISEASE ECHO HAWAII 1/23/17 NONE Blank COMPLEX VALVE CASES ECHO HAWAII 1/23/17 1 David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine Director, Structural Heart Imaging The Ohio State University Division of Cardiovascular Medicine

More information

Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques

Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Treatment of Bio-Prosthetic Valve Deterioration Using Transcatheter Techniques Pablo Codner, Abid Assali, Hanna Vaknin-Assa, Katia Orvin, Ram Sharony, Leor Perl, Gabriel Greenberg, Marina Kupershmidt,

More information

Aortic valve implantation using the femoral and apical access: a single center experience.

Aortic valve implantation using the femoral and apical access: a single center experience. Aortic valve implantation using the femoral and apical access: a single center experience. R. Hoffmann, K. Brehmer, R. Koos, R. Autschbach, N. Marx, G. Dohmen Rainer Hoffmann, University Aachen, Germany

More information

Transcatheter Mitral Valve Replacement How Close Are We?

Transcatheter Mitral Valve Replacement How Close Are We? Transcatheter Mitral Valve Replacement How Close Are We? Gregory Pavlides, MD, PhD, FACC, FESC Professor of Medicine Miscia Chair of Interventional Cardiology Director, Cardiac Catheterization Laboratories,

More information

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair?

TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? TAVI- Is Stroke Risk the Achilles Heel of Percutaneous Aortic Valve Repair? Elaine E. Tseng, MD and Marlene Grenon, MD Department of Surgery Divisions of Adult Cardiothoracic and Vascular and Endovascular

More information

Subacute left ventricular outflow tract obstruction after transapical closure of a mitral paravalvular leak in the region of the aortomitral curtain

Subacute left ventricular outflow tract obstruction after transapical closure of a mitral paravalvular leak in the region of the aortomitral curtain DOI: 10.1111/echo.13357 CASE REPORT Subacute left ventricular outflow tract obstruction after transapical closure of a mitral paravalvular leak in the region of the aortomitral curtain Sathish Chikkabyrappa

More information

Dysfunction of transcatheter mitral valve prosthesis. Early valve degeneration or thrombosis - that is the question.

Dysfunction of transcatheter mitral valve prosthesis. Early valve degeneration or thrombosis - that is the question. Dysfunction of transcatheter mitral valve prosthesis. Early valve degeneration or thrombosis - that is the question. Böhm A., Hricak V., Tomasovic B., Bena M., Postulka J. The National Institute of, Department

More information

TCTAP C-217 Bilateral Pulmonary Arterio Venus Fistula Managed by Vascular Plugs and Coil Manotosh Panja 1 1 BelleVue Clinic, India

TCTAP C-217 Bilateral Pulmonary Arterio Venus Fistula Managed by Vascular Plugs and Coil Manotosh Panja 1 1 BelleVue Clinic, India S450 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, VOL. 65, NO. 17, SUPPL S, 2015 Case Summary. Aneurysm at LVOT is a rare complication after Bentall operation and the aneurysm may increase in size. In

More information

Complicated Percutaneous Repair of a Paravalvular Mitral Leak. Dr. K Kam Resident Specialist Division of Cardiology, PWH M&T (Courtesy: Prof.

Complicated Percutaneous Repair of a Paravalvular Mitral Leak. Dr. K Kam Resident Specialist Division of Cardiology, PWH M&T (Courtesy: Prof. Complicated Percutaneous Repair of a Paravalvular Mitral Leak Dr. K Kam Resident Specialist Division of Cardiology, PWH M&T (Courtesy: Prof. PW Lee) A new job for echo guy Interventional echocardiologist!

More information

TAVR SPRING 2017 The evolution of TAVR

TAVR SPRING 2017 The evolution of TAVR TAVR SPRING 2017 The evolution of TAVR Matthew Johnson, MD Disclosers None Evolution of the Balloon- Expandable Transcatheter Valves Cribier 2002 SAPIEN 2006 SAPIEN XT 2009 SAPIEN 3 2013 * Sheath compatibility

More information

Echocardiographic Evaluation of Mitral Valve Prostheses

Echocardiographic Evaluation of Mitral Valve Prostheses Echocardiographic Evaluation of Mitral Valve Prostheses Dennis A. Tighe, M.D., FACC, FACP, FASE Cardiovascular Medicine University of Massachusetts Medical School Worcester, MA www.asecho.org 1 Nishimura

More information

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC

TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC TREATMENT OF MITRAL REGURGITATION RAJA NAZIR FACC NATURAL HISTORY OF MITRAL REGURGITATION Abdallah El Sabbagh et al. JIMG 2018;11:628-643 TREATMENT OPTIONS SURGERY REPAIR REPLACEMENT PERCUTANEOUS INTERVENTIONS

More information

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY?

HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? HOW IMPORTANT ARE THESE ECHO MEASUREMENTS ANYWAY? John D. Carroll, MD Professor, Director of Interventional Cardiology and Co-Medical Director of the Cardiac and Vascular Center, University of Colorado

More information

MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification. Rheumatic Mitral Stenosis 76yo male

MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification. Rheumatic Mitral Stenosis 76yo male MITRAL STENOSIS: MANY FLAVORS Rheumatic and Calcification David S Rubenson MD FACC FASE Founding Director, Cardiac Non-Invasive Laboratory Scripps Clinic Medical Group number 1 Rheumatic Mitral Stenosis

More information

TEE Zebras. Case Cardiac Anesthesia Group

TEE Zebras. Case Cardiac Anesthesia Group TEE Zebras Edwin G. Avery, IV, M.D., C.P.I. Chief, Division of Cardiac Anesthesia University Hospitals Case Medical Center Associate Professor of Anesthesiology Case Western Reserve University School of

More information

MINIMALLY INVASIVE MITRAL VALVE SURGERY. Rohinton J. Morris, MD Chief, Cardiothoracic Surgery Jefferson University and Health Systems

MINIMALLY INVASIVE MITRAL VALVE SURGERY. Rohinton J. Morris, MD Chief, Cardiothoracic Surgery Jefferson University and Health Systems MINIMALLY INVASIVE MITRAL VALVE SURGERY Rohinton J. Morris, MD Chief, Cardiothoracic Surgery Jefferson University and Health Systems OVERVIEW History Anatomy Indications Techniques Variants Outcomes &

More information

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis?

Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis? EuroValves 2015, Nice Prosthesis-Patient Mismatch or Prosthetic Valve Stenosis? Philippe Pibarot, DVM, PhD, FACC, FAHA, FASE FESC Canada Research Chair in Valvular Heart Diseases Université LAVAL Disclosure

More information

An Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St.

An Update on the Edwards TAVR Results. Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St. An Update on the Edwards TAVR Results Zvonimir Krajcer, MD Director, Peripheral Intervention Texas Heart Institute at St. Luke s Hospital Disclosures On the speaker s bureau for Endologix, TriVascular,

More information

Prince Sultan Cardiac Center Experience Riyadh, Saudi Arabia

Prince Sultan Cardiac Center Experience Riyadh, Saudi Arabia Transcatheter Transapical Aortic Valve Implantation Prince Sultan Cardiac Center Experience Riyadh, Saudi Arabia Ahmed Elwatidy, MD,PhD, FRCS S Kassab, MD,S Ahmari, MD, H Amri, MD, H Ismail, MD, A Calafiori,

More information

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy

TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy TAVR today: High Risk, Intermediate Risk Population, and Valve in Valve Therapy Alan Zajarias, MD FACC Structural Interventional Fellowship Director Associate Professor Medicine Cardiovascular Division

More information

Consideration for Surgical Valves and

Consideration for Surgical Valves and Valve Choice: Consideration for Surgical Valves and Rings for Future Valve-in-Valve Kendra J. Grubb, M.D., M.H.A, F.A.C.C. Surgical Director, Structural Heart and Valve Center Division of Cardiothoracic

More information

Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves

Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Hemodynamics Benefit of Supra-Annular Design in Failed Bio-Prosthetic Valves Speaker's name: I have the following potential conflicts of interest to report: Proctorship for Medtronic Agenda Failure modes

More information

7 th Conference of Transcatheter Heart Valve Therapies

7 th Conference of Transcatheter Heart Valve Therapies 7 th Conference of Transcatheter Heart Valve Therapies May 18-19, 2018, Athens Hilton Athens, Greece Course Directors Stratis Pattakos MD Konstantinos Spargias MD Panos Vardas MD Co-Directors Nick Bouboulis

More information

Menachem M. Weiner Assistant Professor of Anesthesiology Icahn School of Medicine at Mount Sinai

Menachem M. Weiner Assistant Professor of Anesthesiology Icahn School of Medicine at Mount Sinai Menachem M. Weiner Assistant Professor of Anesthesiology Icahn School of Medicine at Mount Sinai Anesthetic care and considerations Intraoperative events TEE Perioperative complications Most common valvular

More information

My Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD.

My Choice For Percutaneous Mitral Valve Replacement. Jose Luis Navia, MD. My Choice For Percutaneous Mitral Valve Replacement Jose Luis Navia, MD. Disclosure Edwards Lifescienses St. Jude Medical MAQUET NaviGate Consultant, Investigator Consultant, Investigator Consultant, Investigator

More information

Successful Transfemoral Edwards Sapien Aortic. Valve Implantation in a Patient with Previous. Mitral Valve Replacement

Successful Transfemoral Edwards Sapien Aortic. Valve Implantation in a Patient with Previous. Mitral Valve Replacement Advanced Studies in Medical Sciences, Vol. 2, 2014, no. 1, 37-45 HIKARI Ltd, www.m-hikari.com http://dx.doi.org/10.12988/asms.2014.31213 Successful Transfemoral Edwards Sapien Aortic Valve Implantation

More information

THE PERCUTANEOUS MANAGEMENT OF VALVULAR HEART DISEASE DR JOHN RAWLINS CONSULTANT INTERVENTIONAL CARDIOLOGIST UNIVERSITY HOSPITAL SOUTHAMPTON

THE PERCUTANEOUS MANAGEMENT OF VALVULAR HEART DISEASE DR JOHN RAWLINS CONSULTANT INTERVENTIONAL CARDIOLOGIST UNIVERSITY HOSPITAL SOUTHAMPTON THE PERCUTANEOUS MANAGEMENT OF VALVULAR HEART DISEASE DR JOHN RAWLINS CONSULTANT INTERVENTIONAL CARDIOLOGIST UNIVERSITY HOSPITAL SOUTHAMPTON INTRODUCTION History of heart valve intervention Current indications

More information

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School

Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of Medicine Harvard Medical School Aortic Stenosis: Current State of Percutaneous Therapies, Emerging Technologies and Future Directions Igor Palacios, MD Director of Interventional Cardiology Massachusetts General Hospital Professor of

More information

Indication, Timing, Assessment and Update on TAVI

Indication, Timing, Assessment and Update on TAVI Indication, Timing, Assessment and Update on TAVI Swedish Heart and Vascular Institute Ming Zhang MD PhD Interventional Cardiology Structure Heart Disease Conflict of Interest None Starr- Edwards Mechanical

More information

CARDIOLOGY GRAND ROUNDS

CARDIOLOGY GRAND ROUNDS CARDIOLOGY GRAND ROUNDS Presentation: Speakers: Percutaneous Repair of Paravalvular Prosthetic Regurgitation Paul Sorajja, MD Director of the Center for Valve and Structural Heart Disease Minneapolis Heart

More information

Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D.

Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D. Valve Replacement without a Scalpel Transcatheter Aortic Valve Replacement (TAVR) Charles T. Klodell, M.D. Professor, Thoracic and Cardiovascular Surgery University of Florida klodell@surgery.ufl.edu Disclosures

More information

Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement Transcatheter Aortic Valve Replacement Jesse Jorgensen, MD Medical Director, Cardiac Catheterization Laboratory Greenville Health System Greenville, South Carolina, USA January 30, 2016 Aortic Stenosis

More information

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim

42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim 42yr Old Male with Severe AR Mild LV dysfunction s/p TOF -AV Replacement(tissue valve) or AoV plasty- Kyung-Hwan Kim Current Guideline for AR s/p TOF Surgery is reasonable in adults with prior repair of

More information

Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute

Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute Mechanical vs. Bioprosthetic Aortic Valve Replacement: Time to Reconsider? Christian Shults, MD Cardiac Surgeon, Medstar Heart and Vascular Institute Assistant Professor, Georgetown School of Medicine

More information

DISCLOSURE. Relevant Financial Relationship(s) Off Label Usage. None. None

DISCLOSURE. Relevant Financial Relationship(s) Off Label Usage. None. None Echo for TAVR Sunil Mankad, MD, FACC, FCCP, FASE Associate Professor of Medicine Mayo Clinic College of Medicine Director, Transesophageal Echocardiography Associate Director, Cardiology Fellowship Mayo

More information

Rapid deployment aortic valve replacement for the treatment of severe aortic stenosis in high risk patients. Β. Κόλλιας, Σ. Ματιάτου, Δ. Αγγουράς.

Rapid deployment aortic valve replacement for the treatment of severe aortic stenosis in high risk patients. Β. Κόλλιας, Σ. Ματιάτου, Δ. Αγγουράς. Rapid deployment aortic valve replacement for the treatment of severe aortic stenosis in high risk patients. Οι βιοπροσθετικές αορτικές βαλβίδες ταχείας έκπτυξης στην αντιµετώπιση της σοβαρής αορτικής

More information

APOLLO TMVR Trial Update: Case Presentation

APOLLO TMVR Trial Update: Case Presentation APOLLO TMVR Trial Update: Case Presentation Anelechi Anyanwu, MD, MSc, FRCS-CTh Professor and Vice-Chairman Department of Cardiovascular Surgery Icahn School of Medicine at Mount Sinai New York, NY Disclosure

More information

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology

New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor. Cardiothoracic Radiology New Cardiovascular Devices and Interventions: Non-Contrast MRI for TAVR Abhishek Chaturvedi Assistant Professor Cardiothoracic Radiology Disclosure I have no disclosure pertinent to this presentation.

More information

TEE guided TAVR using BASILICA technique in patient with stenotic Freestyle aortic bioprosthesis

TEE guided TAVR using BASILICA technique in patient with stenotic Freestyle aortic bioprosthesis TEE guided TAVR using BASILICA technique in patient with stenotic Freestyle aortic bioprosthesis Zuyue Wang MD Associate professor, Georgetown University School of Medicine MedStar Heart and Vascular Institute

More information

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions

Percutaneous Tricuspid Valve Therapies: The Next Frontier? Is the Tricuspid Valve Relevant? Data and Guidelines for TV Interventions Percutaneous Tricuspid Valve Therapies: The Next Frontier? Scott M Lilly, MD PhD The Ohio State University Structural Heart Disease Course May 19 th, 2017 Outline Is the Tricuspid Valve Relevant? Data

More information

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504

Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This

More information

Stress Testing in Valvular Disease

Stress Testing in Valvular Disease 2017 ASE Florida Orlando, FL October 10, 2017 2:40 2:50 PM 10 min Grand Harbor Ballroom South Stress Testing in Valvular Disease Muhamed Sarić MD, PhD, MPA Director of Noninvasive Cardiology Echo Lab Associate

More information

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM

Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM The Patient with Aortic Stenosis and Mitral Regurgitation Prof. Patrizio LANCELLOTTI, MD, PhD Heart Valve Clinic, University of Liège, CHU Sart Tilman, Liège, BELGIUM Aortic Stenosis + Mitral Regurgitation?

More information

Late secondary TR after left sided heart disease correction: is it predictibale and preventable

Late secondary TR after left sided heart disease correction: is it predictibale and preventable Late secondary TR after left sided heart disease correction: is it predictibale and preventable Gilles D. Dreyfus Professor of Cardiothoracic surgery Nath J, et al. JACC 2004 PREDICT Incidence of secondary

More information

Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, :50 2:10 PM 20 min

Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, :50 2:10 PM 20 min 2016 ASE State of the Art Echocardiography Course Tucson, AZ Echo Evaluation of a Mitral Valve Prostheses Sunday, February 14, 2016 1:50 2:10 PM 20 min 1 M U H A M E D S A R I Ć, M D, P H D D i r e c t

More information

Aortic Stenosis Background and Breakthroughs in Treatment: TAVR Update

Aortic Stenosis Background and Breakthroughs in Treatment: TAVR Update Aortic Stenosis Background and Breakthroughs in Treatment: TAVR Update Howard J Broder MD Interventional Cardiology DaVita Medical Group/ Healthcare Partners Cardiology Disclosures for Howard J Broder

More information

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central

TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central TAVR-Update Andrzej Boguszewski MD, FACC, FSCAI Vice Chairman, Cardiology Mid-Michigan Health Associate Professor Michigan State University, Central Michigan University 1 Disclosure Chiesi Pharma- Consultant

More information

SAPIEN 3 Sizing Considerations:

SAPIEN 3 Sizing Considerations: SAPIEN 3 Sizing Considerations: Oversizing, Undersizing, or Volume reduction? John Webb MD St Paul s Hospital University of British Columbia Vancouver Disclosure Statement of Financial Interest Within

More information

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017

Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical. The Houston Aortic Symposium February 23-25, 2017 James S. Gammie, MD Professor and Chief, Division of Cardiac Surgery Chief Medical Officer, Harpoon Medical The Houston Aortic Symposium February 2-25, 2017 Disclosure Statement of Financial Interest Within

More information

Prosthetic valve dysfunction: stenosis or regurgitation

Prosthetic valve dysfunction: stenosis or regurgitation Prosthetic valve dysfunction: stenosis or regurgitation Jean G. Dumesnil MD, FRCP(C), FACC, FASE(Hon) Quebec Heart and Lung Institute, Québec, Québec No disclosures Possible Causes of High Gradients in

More information

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz

Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Hani K. Najm MD, Msc, FRCSC FACC, FESC President Saudi Society for Cardiac Surgeons Associate Professor of Cardiothoracic Surgery King Abdulaziz Cardiac Centre Riyadh, Saudi Arabia Decision process for

More information

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR)

Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR) Minimalist Transcatheter Aortic Valve Replacement (MA-TAVR) Jensen HA, Condado JF, Devireddy C, Binongo JN, Leshnower BG, Babaliaros V, Sarin EL, Lerakis S, Guyton RA, Stewart JP, Syed AQ, Mavromatis K,

More information

Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques

Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques Minimally Invasive Aortic Surgery With Emphasis On Technical Aspects, Extracorporeal Circulation Management And Cardioplegic Techniques Konstadinos A Plestis, MD System Chief of Cardiothoracic and Vascular

More information

Zanobini et al. Journal of Cardiothoracic Surgery (2017) 12:114 DOI /s

Zanobini et al. Journal of Cardiothoracic Surgery (2017) 12:114 DOI /s Zanobini et al. Journal of Cardiothoracic Surgery (2017) 12:114 DOI 10.1186/s13019-017-0680-7 CASE REPORT Emergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical

More information

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation

Prof. Dr. Thomas Walther. TAVI in ascending aorta / aortic root dilatation Prof. Dr. Thomas Walther TAVI in ascending aorta / aortic root dilatation nn AorticStenosis - Guidelines TAVI and aortic aneurysm? Few data published. EJCTS 2014;46:228-33 TAVI and aortic aneurysm? Few

More information

TAVI IN BICUSPID AOV AND VALVE-IN-VALVE

TAVI IN BICUSPID AOV AND VALVE-IN-VALVE TAVI IN BICUSPID AOV AND VALVE-IN-VALVE Petros S. Dardas, MD, FESC St Lukes Hospital Thessaloniki, GREECE 6o ΣΥΝΕΔΡΙΟ ΔΙΑΚΑΘΕΤΗΡΙΑΚΗΣ ΘΕΡΑΠΕΙΑΣ ΚΑΡΔΙΑΚΩΝ ΒΑΛΒΙΔΟΠΑΘΕΙΩΝ ΑΘΗΝΑ 2017 BICUSPID AOV Surgical

More information

Echocardiographic Evaluation of Aortic Valve Prosthesis

Echocardiographic Evaluation of Aortic Valve Prosthesis Echocardiographic Evaluation of Aortic Valve Prosthesis Amr E Abbas, MD, FACC, FASE, FSCAI, FSVM, RPVI Director, Interventional Cardiology Research, Beaumont Health System Associate Professor of Medicine,

More information

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, Pennsylvania USA

William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, Pennsylvania USA William A. Gray MD System Chief of Cardiovascular Services, Main Line Health President, Lankenau Heart Institute Wynnewood, Pennsylvania USA Mitral Valve Disease Today Mitral regurgitation is the most

More information

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea

Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Surgical AVR: Are there any contraindications? Pyowon Park Samsung Medical Center Seoul, Korea Contents Decision making in surgical AVR in old age Clinical results of AVR with tissue valve Impact of 19mm

More information

Emergency TAVI: Does It Exist? Is the Risk Higher?

Emergency TAVI: Does It Exist? Is the Risk Higher? Emergency TAVI: Does It Exist? Is the Risk Higher? Gerald Yong MBBS (Hons) FRACP FSCAI Interventional Cardiologist Royal Perth Hospital Western Australia APCASH 12 October 2014 Disclosure Statement of

More information

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics.

Echo Doppler Assessment of Right and Left Ventricular Hemodynamics. Echo Doppler Assessment of Right and Left Ventricular Hemodynamics. Itzhak Kronzon, MD, FASE, FACC, FESC, FAHA, FACP, FCCP Northwell, Lenox Hill Hospital, New York Professor of Cardiology Hofstra University

More information

CoreValve in a Degenerative Surgical Valve

CoreValve in a Degenerative Surgical Valve CoreValve in a Degenerative Surgical Valve Ran Kornowski, MD, FESC, FACC Chairman Department of Cardiology Rabin Medical Center, Petach Tikva, Israel Disclosure Statement of Financial Interest I, Ran Kornowski,

More information

The Ohio State University Columbus, Ohio, USA

The Ohio State University Columbus, Ohio, USA 8 th National ACHA Conference, June 3 rd, 2017, Orlando, FL Transcatheter Heart Valves A Hybrid Approach Let s Work Together John P. Cheatham, MD, MSCAI George H. Dunlap Endowed Chair in Interventional

More information

Paravalvular Regurgitation is a Risk Factor Following TAVI

Paravalvular Regurgitation is a Risk Factor Following TAVI Paravalvular Regurgitation is a Risk Factor Following TAVI Philippe Pibarot, DVM, PhD, FACC, FESC, FASE Canada Research Chair in Valvular Heart Disease INSTITUT UNIVERSITAIRE DE CARDIOLOGIE ET DE PNEUMOLOGIE

More information

1-YEAR OUTCOMES FROM JOHN WEBB, MD

1-YEAR OUTCOMES FROM JOHN WEBB, MD 1-YEAR OUTCOMES FROM JOHN WEBB, MD ON BEHALF OF THE SAPIEN 3 INVESTIGATORS UNIVERSITY OF BRITISH COLUMBIA VANCOUVER, CANADA Potential conflicts of interest Speaker's name: John Webb I have the following

More information

TAVR in 2020: What is Next!!!!

TAVR in 2020: What is Next!!!! TAVR in 2020: What is Next!!!! Vinod H. Thourani, MD Professor of Surgery Chairman, Department of Cardiac Surgery Medstar Heart and Vascular Institute Washington Hospital Center Washington, DC Disclosures

More information

TAVR IN INTERMEDIATE-RISK PATIENTS

TAVR IN INTERMEDIATE-RISK PATIENTS TAVR IN INTERMEDIATE-RISK PATIENTS K. Lampropoulos MD, PhD, FESC, MEAPCI Interventional Cardiologist Evangelismos General Hospital The Burden of Valve Disease Prevalence Survival NATURAL HISTORY OF AS

More information

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University

Assessment and Preparation of Patients with TAVI. Rob Tanzola Associate Professor, Queen s University Assessment and Preparation of Patients with TAVI Rob Tanzola Associate Professor, Queen s University My patient has aortic stenosis and needs non-cardiac surgery Should (s)he get a TAVI? Rob Tanzola Associate

More information

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines

Outline 9/17/2016. Advances in Percutaneous Mitral Valve Repair and Replacement. Scope of the Problem and Guidelines Advances in Percutaneous Mitral Valve Repair and Replacement Scott M Lilly MD PhD, Interventional Cardiology The Ohio State University Contemporary Multidisciplinary Cardiovascular Conference Orlando,

More information

Echocardiographic Evaluation of Aortic Valve Prosthesis

Echocardiographic Evaluation of Aortic Valve Prosthesis Echocardiographic Evaluation of Aortic Valve Prosthesis Amr E Abbas, MD, FACC, FASE, FSCAI, FSVM, RPVI Co Director, Echocardiography, Director, Interventional Cardiology Research, Beaumont Health System

More information

2/10/2012. The Role of Multimodality Imaging in Percutaneous Valve Interventions. This is truly a TEAM work. Overview. Overview

2/10/2012. The Role of Multimodality Imaging in Percutaneous Valve Interventions. This is truly a TEAM work. Overview. Overview The Role of Multimodality Imaging in Percutaneous Valve Interventions João L. Cavalcante, MD Advanced Cardiovascular Imaging Cleveland Clinic 02/11/2012 Disclosures: None Movement from surgery to transcatheter

More information

Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY)

Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY) Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY) Thomas Walther, Christian W. Hamm, Gerhard Schuler, Alexander Berkowitsch,

More information

Cardiac Valve/Structural Therapies

Cardiac Valve/Structural Therapies Property of Dr. Chad Rammohan Cardiac Valve/Structural Therapies Chad Rammohan, MD FACC Medical Director, El Camino Hospital Cardiac Catheterization Lab Director, Interventional and Structural Cardiology,

More information

Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland

Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland Andrzej Ochala, MD Medical University of Silesia, Katowice, Poland Bicuspid aortic valve o Most common congenital heart disease in adults (1% - 2%) o AS is the most common complication of BAV o Patophysiology

More information

Outcome of Next-Generation Transcatheter Valves in Small Aortic Annuli: A Multicenter Propensity-Matched Comparison

Outcome of Next-Generation Transcatheter Valves in Small Aortic Annuli: A Multicenter Propensity-Matched Comparison Outcome of Next-Generation Transcatheter Valves in Small Aortic Annuli: A Multicenter Propensity-Matched Comparison Mauri, V. et al.: Circ Cardiovasc Interv. 2017;10:e005013 All trademarks are the property

More information

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH

TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH Available systems: Edwards (TA and TF) and Core valve. INTRODUCTION 3 4% 0f > 65 y. 30 40% of elderly denied surgery,.

More information

Transcatheter Mitral Valve for fmr: The Era of Too Many Options

Transcatheter Mitral Valve for fmr: The Era of Too Many Options Transcatheter Mitral Valve for fmr: The Era of Too Many Options Isaac George, M.D. Surgical Director, Structural Heart & Valve Center Assistant Professor of Surgery Columbia University Medical Center Disclosure

More information

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal I have nothing to disclose. Wide Spectrum Stable vs Decompensated NYHA II IV? Ejection

More information

Optimal Imaging Technique Prior to TAVI -Echocardiography-

Optimal Imaging Technique Prior to TAVI -Echocardiography- 2014 KSC meeting Optimal Imaging Technique Prior to TAVI -Echocardiography- Geu-Ru Hong, M.D. Ph D Associate Professor of Medicine Division of Cardiology, Severance Cardiovascular Hospital Yonsei University

More information

Cite this article as:

Cite this article as: doi: 10.21037/acs.2018.09.05 Cite this article as: Cheung A. Early experience of TIARA transcatheter mitral valve replacement system.. doi: 10.21037/acs.2018.09.05 This is a PDF file of an edited manuscript

More information

Transcatheter Valve Replacement: Current State in 2017

Transcatheter Valve Replacement: Current State in 2017 Transcatheter Valve Replacement: Current State in 2017 Marc A. Sintek MD Assistant Professor of Medicine Interventional Cardiology Cardiovascular Division Washington University in St. Louis Missouri ACP

More information

Late failure of transcatheter heart valves: An open question

Late failure of transcatheter heart valves: An open question Late failure of transcatheter heart valves: An open question A comparison with surgically implanted bioprosthetic heart valves. A. Rashid The Cardiothoracic Centre Liverpool, UK. Conflict of Interest Statement

More information